vs
Side-by-side financial comparison of Electromed, Inc. (ELMD) and Integer Holdings Corp (ITGR). Click either name above to swap in a different company.
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
Integer Holdings Corp is a global medical device contract manufacturing partner for leading healthcare and medtech enterprises. It designs, develops and produces high-precision components, assemblies and finished medical devices across core segments including cardiac care, neuromodulation, orthopedics and portable medical products, serving markets across North America, Europe and Asia-Pacific.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.9M | — | ||
| Q3 25 | $16.9M | — | ||
| Q2 25 | $17.4M | — | ||
| Q1 25 | $15.7M | — | ||
| Q4 24 | $16.3M | — | ||
| Q3 24 | $14.7M | — | ||
| Q2 24 | $14.8M | — | ||
| Q1 24 | $13.9M | — |
| Q4 25 | $2.8M | — | ||
| Q3 25 | $2.1M | — | ||
| Q2 25 | $2.2M | — | ||
| Q1 25 | $1.9M | — | ||
| Q4 24 | $2.0M | — | ||
| Q3 24 | $1.5M | — | ||
| Q2 24 | $1.8M | — | ||
| Q1 24 | $1.5M | — |
| Q4 25 | 78.4% | — | ||
| Q3 25 | 78.1% | — | ||
| Q2 25 | 78.3% | — | ||
| Q1 25 | 78.0% | — | ||
| Q4 24 | 77.7% | — | ||
| Q3 24 | 78.3% | — | ||
| Q2 24 | 76.2% | — | ||
| Q1 24 | 74.8% | — |
| Q4 25 | 19.2% | — | ||
| Q3 25 | 15.8% | — | ||
| Q2 25 | 17.5% | — | ||
| Q1 25 | 13.6% | — | ||
| Q4 24 | 15.6% | — | ||
| Q3 24 | 13.2% | — | ||
| Q2 24 | 15.7% | — | ||
| Q1 24 | 13.3% | — |
| Q4 25 | 14.6% | — | ||
| Q3 25 | 12.6% | — | ||
| Q2 25 | 12.7% | — | ||
| Q1 25 | 12.1% | — | ||
| Q4 24 | 12.1% | — | ||
| Q3 24 | 10.0% | — | ||
| Q2 24 | 12.3% | — | ||
| Q1 24 | 10.8% | — |
| Q4 25 | $0.32 | — | ||
| Q3 25 | $0.25 | — | ||
| Q2 25 | $0.26 | — | ||
| Q1 25 | $0.21 | — | ||
| Q4 24 | $0.22 | — | ||
| Q3 24 | $0.16 | — | ||
| Q2 24 | $0.20 | — | ||
| Q1 24 | $0.17 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
